Nektar Therapeutics
NKTR
NKTR
237 hedge funds and large institutions have $949M invested in Nektar Therapeutics in 2022 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 88 increasing their positions, 64 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
17% less call options, than puts
Call options by funds: $31.5M | Put options by funds: $38M
60% less capital invested
Capital invested by funds: $2.35B → $949M (-$1.4B)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
237
Holding in Top 10
–
Calls
$31.5M
Puts
$38M
Top Buyers
| 1 | +$5.23M | |
| 2 | +$4.95M | |
| 3 | +$4.68M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.46M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$3.7M |
Top Sellers
| 1 | -$35.1M | |
| 2 | -$13.3M | |
| 3 | -$7.57M | |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
-$5.55M |
| 5 |
BlackRock
New York
|
-$3M |